Literature DB >> 11328238

Symptomatic recovery and social functioning in major depression.

T A Furukawa1, H Takeuchi, T Hiroe, H Mashiko, K Kamei, T Kitamura, K Takahashi.   

Abstract

OBJECTIVE: To determine whether social functional recovery precedes, runs in parallel with, or lags behind symptomatic recovery from major depressive episodes.
METHOD: Psychiatric out-patients or in-patients aged 18 years or over, diagnosed with unipolar major depressive disorder according to DSM-IV, and who had received no antidepressant medication in the preceding 3 months were identified at 23 collaborating centres from all over Japan (n=95). They were rated with the 17-item Hamilton Rating Scale for Depression (HRSD) and the Global Assessment Scale (GAS) monthly, and with the Social Adjustment Scale-Self Report (SAS-SR) 6-monthly. Remission was defined as 7 or less on the HRSD and recovery as 2 or more consecutive months of remission.
RESULTS: The GAS ratings showed continuous amelioration from baseline to remission, remission to recovery, and after sustained recovery. The same trends were observed for SAS-SR scores.
CONCLUSION: We can expect further amelioration in social adjustment after symptomatic remission and recovery of major depressive episodes.

Entities:  

Mesh:

Year:  2001        PMID: 11328238     DOI: 10.1034/j.1600-0447.2001.00140.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2014-07-21

2.  Social functioning in young people at risk for schizophrenia.

Authors:  Jacob S Ballon; Tejal Kaur; Iliana I Marks; Kristin S Cadenhead
Journal:  Psychiatry Res       Date:  2007-03-26       Impact factor: 3.222

Review 3.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

4.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

Review 5.  [Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Authors:  Christine Maria Hörtnagl; Stefan Oberheinricher; Alex Hofer
Journal:  Neuropsychiatr       Date:  2014-06-11

Review 6.  The impact of residual symptoms on outcome of major depression.

Authors:  Noel Kennedy; Kevin Foy
Journal:  Curr Psychiatry Rep       Date:  2005-12       Impact factor: 8.081

7.  Alexithymia and somatisation in patients with remitted major depression and their impact on social functioning.

Authors:  Hakan Delibas; Asusinem A Kirdok; Almila Erol
Journal:  S Afr J Psychiatr       Date:  2016-10-21       Impact factor: 1.550

8.  Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy.

Authors:  Atsushi Kuga; Tempei Otsubo; Toshinaga Tsuji; Shinji Hayashi; Hideyuki Imagawa; Shinji Fujikoshi; Rodrigo Escobar
Journal:  Neuropsychiatr Dis Treat       Date:  2019-04-05       Impact factor: 2.570

9.  Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study.

Authors:  Jitsuki Sawamura; Jun Ishigooka; Katsuji Nishimura
Journal:  Health Qual Life Outcomes       Date:  2018-01-16       Impact factor: 3.186

10.  Delineating the trajectories of social and occupational functioning of young people attending early intervention mental health services in Australia: a longitudinal study.

Authors:  Frank Iorfino; Daniel F Hermens; Shane Pm Cross; Natalia Zmicerevska; Alissa Nichles; Caro-Anne Badcock; Josine Groot; Elizabeth M Scott; Ian B Hickie
Journal:  BMJ Open       Date:  2018-03-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.